NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
Arshad Khan(King Fahd University of Petroleum and Minerals), Chinnaswamy Jagannath(Houston Methodist)
Cited by 25
Related Papers
CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice
|Journal of Controlled Release|2022|15